IMAGENIUM develops the dynamic study of the interactions molecular and supra molecular in situ after exogenic stimuli (bio-active molecules, hormones, molecules under development in cancerology).

The analysis of the trajectories and the quantification of the signals in the various cellular compartments constitute a major subject of the company. The analysis is carried out by systems of instrumentation automated on animal cells, fabrics and models in vivo.

The IMAGENIUM company is a private company which was created by L. Faure in FRANCE in 2002, it proposes a innovating approach which relates to the molecular targeting in situ, visualization in photonic microscopy, the cellular imagery and the nanoscopy and of transfection to accelerate the discovery of new pharmaceutical molecules and their effects on the functional architecture of the cell.

IMAGENIUM has programs of development directed towards the cancerology, the menopause, ageing and the active beauty care.

IMAGENIUM has a technology which combines cellular visualization with a multimode analysis of the high flow screening and systems of instrumentation automated of cellular analysis, integratives data bases and data-processing software owners.

The mission of IMAGENIUM is to elucidate the complex interactions of the bio-active molecules in the cellular compartments. The objective is the integration of leading-edge technologies in cellular and molecular biology, fluorescent microscopy and spectroscopy, of process of indication and into bioinformatic. IMAGENIUM is centered on the development and the implementation of techniques of microscopy advanced to visualize and measure kinetic processes in the alive cells or fabrics or the living organisms.